Is Citius Pharmaceuticals Inc (NASDAQ: CTXR) Back In The Buying Zone?
Currently, there are 11.17M common shares owned by the public and among those 10.53M shares have been available to trade. The company’s stock has a 5-day price change of 63.27% and -16.77% over the past three months. CTXR shares are trading -91.94% year to date (YTD), with the 12-month market performance down to -67.75% lower. […]